MLchartDataset catalogue

Torisel

Term · Oncology and biomedicine · MLC-T-ONC-008767

A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Torisel blocks a protein called mTOR, which helps control cell division. Blocking this protein may help keep cancer cells from growing. Torisel is a type of kinase inhibitor. Also called CCI-779 and temsirolimus.

Table 1. Record
IdentifierMLC-T-ONC-008767
FieldOncology and biomedicine
SynonymsCCI-779; temsirolimus
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-008767",
  "term": "Torisel",
  "field": "Oncology and biomedicine",
  "definition": "A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also being studied in the treatment of other types of cancer. Torisel blocks a protein called mTOR, which helps control cell division. Blocking this protein may help keep cancer cells from growing. Torisel is a type of kinase inhibitor. Also called CCI-779 and temsirolimus.",
  "synonyms": [
    "CCI-779",
    "temsirolimus"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/torisel/"
}

Record 16,530 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.